Deborah Korbitz
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 63.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $840 and has fallen 97.5% since, to $21 in 2025.
Across 135 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Collegium Pharmaceutical, Inc.$330
- Stryker$108
- Valinor Pharma, LLC$91
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$80
- Protega Pharmaceutials Inc$52
- plus $298 from 12 others
What the payments were for
- Food & beverage$2,643100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 83 | $1,684 |
| Collegium Pharmaceutical, Inc. | 25 | $330 |
| Stryker | 1 | $108 |
| Valinor Pharma, LLC | 4 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $80 |
| Protega Pharmaceutials Inc | 3 | $52 |
| Saluda Medical Americas, Inc. | 1 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Boston Scientific | 2 | $36 |
| Almatica Pharma LLC | 1 | $28 |
| Electronic Waveform Lab, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Medtronic | 1 | $21 |
| Bioventus LLC | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRODIGY$140
- PROCLAIM$118
- Proclaim IPG$116
- mild Device Kit$108
- PROTG$102
How this compares
$2,643 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 106 | $40,991 |
| MovantikNaloxegol Oxalate | 80 | $33,820 |
| Oxycodone Hcl | 876 | $17,310 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 424 | $17,163 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 217 | $9,211 |
| SymproicNaldemedine Tosylate | 17 | $7,990 |
| Buprenorphine | 34 | $6,931 |
| Gabapentin | 462 | $6,920 |
| Morphine Sulfate ErMorphine Sulfate | 267 | $6,484 |
| Tizanidine Hcl | 262 | $5,068 |
| Pregabalin | 191 | $4,226 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $2,939 |
| Naloxone Hcl | 41 | $2,574 |
| Morphine Sulfate | 68 | $2,408 |
| Lidocaine | 34 | $2,173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $330 | $40,991106 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.
Other family in Mesa
- Sharon MagalonaMesa$441K
- Rebecca McCollaumMesa$149K
- Angela StuffMesa$22K
- Maria Norivic SorianoMesa$15K
- Kelly MatthewsMesa$15K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.